{
    "clinical_study": {
        "@rank": "122872", 
        "arm_group": {
            "arm_group_label": "Volunteer group", 
            "arm_group_type": "Experimental", 
            "description": "Baseline blood draw followed by colchicine followed by blood draw 2 hours and 24 hours later"
        }, 
        "brief_summary": {
            "textblock": "This is a pilot study. Volunteers will be given 1.8 mg (1.2 mg followed by 0.6 mg one hour\n      later), 1.2 mg, or 0.6 mg of colchicine. Blood will be collected prior to drug\n      administration, 2 hours after colchicine administration, and 24 hours after colchicine\n      administration via the antecubital vein and evaluated for markers of platelet activity and\n      inflammation."
        }, 
        "brief_title": "Anti-platelet Effects of Colchicine", 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects must be more than 18 years of age\n\n        Exclusion Criteria:\n\n        1) history of cardiovascular disease, including myocardial infarction, history of\n        percutaneous coronary angioplasty or stent, peripheral vascular disease or stroke; 2)\n        history of myelodysplasia; 3) medications known to affect platelet function, including\n        non-steroidal anti-inflammatory drugs, antihistamines, and selective serotonin reuptake\n        inhibitors, during the 5 days prior to participation; 4) medications known to interact\n        with colchicine; 5) history of intolerance to colchicine; 6) acute or chronic symptoms of\n        diarrhea, nausea, or vomiting within 1 month prior to enrollment; 7) known anemia or\n        hemoglobin <10mg/dL; 8) platelet count <100,000 or > 450,000; 9) creatinine clearance\n        <30cc/minute; 10) any known hemorrhagic diathesis; 11) pregnant; 12) Unable to consent; or\n        13) Participating in a competing study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02140372", 
            "org_study_id": "S13-00747"
        }, 
        "intervention": {
            "arm_group_label": "Volunteer group", 
            "intervention_name": "Colchicine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Colchicine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "colchicine", 
            "platelet activity", 
            "neutrophil"
        ], 
        "lastchanged_date": "May 21, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10016"
                }, 
                "name": "New York University School of Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Anti-platelet Effects of Colchicine in Healthy Volunteers", 
        "overall_contact": {
            "email": "bhisham.harchandani@nyumc.org", 
            "last_name": "Bhisham Harchandani", 
            "phone": "212-263-4194"
        }, 
        "overall_official": {
            "affiliation": "NYU SOM", 
            "last_name": "Binita Shah, MD, MS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "monocyte platelet aggregate", 
            "safety_issue": "No", 
            "time_frame": "change from baseline pre-drug to 2 hour post-drug"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02140372"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "leukocyte platelet aggregation", 
                "safety_issue": "No", 
                "time_frame": "change from baseline pre-drug to 2 hours post-drug"
            }, 
            {
                "measure": "light transmission aggregometry", 
                "safety_issue": "No", 
                "time_frame": "change from baseline pre-drug to 2 hours post-drug"
            }, 
            {
                "measure": "L-selectin", 
                "safety_issue": "No", 
                "time_frame": "change from baseline pre-drug to 2 hours post-drug"
            }, 
            {
                "measure": "platelet adhesion", 
                "safety_issue": "No", 
                "time_frame": "change from baseline pre-drug to 2 hours post-drug"
            }
        ], 
        "source": "New York University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "New York University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}